Apogee Therapeutics, Inc. (APGE)
87.48
+4.76
(+5.75%)
USD |
NASDAQ |
Jun 11, 15:02
Apogee Therapeutics Total Assets (Quarterly) : 1.294B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.294B |
| December 31, 2025 | 937.13M |
| September 30, 2025 | 626.16M |
| June 30, 2025 | 657.77M |
| March 31, 2025 | 714.16M |
| December 31, 2024 | 753.95M |
| September 30, 2024 | 776.29M |
| Date | Value |
|---|---|
| June 30, 2024 | 800.66M |
| March 31, 2024 | 823.66M |
| December 31, 2023 | 401.40M |
| September 30, 2023 | 426.42M |
| June 30, 2023 | 130.67M |
| March 31, 2023 | 142.02M |
| December 31, 2022 | 152.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Evommune, Inc. | 322.46M |
| Cogent Biosciences, Inc. | 903.01M |
| Kymera Therapeutics, Inc. | 1.669B |
| Erasca, Inc. | 461.23M |
| GRAIL, Inc. | 2.803B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.86M |
| Shareholders Equity (Quarterly) | 1.256B |
| Debt to Equity Ratio | 0.0064 |
| Current Ratio | 32.59 |
| Net Debt Paydown Yield | 0.01% |